<unk>  three-dimensional structure<unk>  is used to treat hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction. It has been proven to protect the function of the kidneys in hypertension, heart failure, and diabetes, and may be used in the absence of hypertension for its kidney protective effects. It is widely used in chronic kidney failure. Furthermore,<unk>  is an emerging treatment for psychogenic polydipsia. A double-blind, placebo-controlled trial showed that when used for this purpose,<unk>  led to decreased water consumption (determined by urine output and osmolality) in 60% of patients. Pregnancy and breastfeeding<unk>  is pregnancy category D. Some evidence suggests it will cause injury and death to a developing fetus. Patients are advised not to become pregnant while taking<unk>  and to notify their doctors immediately if they become pregnant. In pregnancy,<unk>  may result in damage to the fetus's kidneys and resulting oligohydramnios (not<unk> ough amniotic fluid).<unk>  is secreted in breast milk and is not recommended for use while breastfeeding.
Enalapril
Quinapril
Telmisartan
Trandolapril
Irbesartan
Lisinopril
Valsartan
Azilsartan